Für viele Städte ist eine klimafreundliche Mobilität eine Herausforderung, der sie sich zunehmend stellen. Viele Fragen stehen im Raum: wie sieht Mobilität und eine Stadt von morgen aus? Wie komme ich klima- und umweltfreundlich zur Schule und zur Arbeit? Was für eine Wende ist dafür nötig un...d wie könnte diese aussehen? Das Unterrichtsmaterial „Verkehr(t)!“ regt die Schüler*innen dazu an, das Verkehrsverhalten in ihrer Umwelt zu analysieren und ihre eigene Mobilität kritisch unter die Lupe zu nehmen. Sie erkunden, welche Bedeutung Verkehr für Umwelt und Klima hat und identifizieren Stellen, an denen Handeln möglich und notwendig ist.
more
The idea to the ANDEMIA online course manual is based on the challenge that resources for sending ANDEMIA students to a variety of face to face courses is limited not only due to financial but also time constraints. Online course provide a good basis for the students, Master, PhD and Post Docs to pr...ovide them with an overview about certain topics and help them to identify their own gaps and needs. They can create more interest for a specific field and build demand for more advanced knowledge on specific topics.
The courses and resources in this manual are meant to reflect a variety of online courses selected from different universities and organisations on topics perceived to be useful for ANDEMIA students. Albeit not complete, we believe that the selection of courses in this manual covers quite comprehensively a wide range of topics.
more
- Conference summary report
(für Asylsuchende, Geflüchtete und Anerkannte). Handreichung zum Infektionsschutz in Einrichtungen zur gemein-schaftlichen Unterbringung (EgU) von Asylbewerbern
Stand März 2022
Zarazne bolesti kao što je virus COVID-19 mogu poremetiti okruženje u kojem djeca rastu i razvijaju se. Remećenje u odnosu sa porodicom, prijateljima, svakodnevnim aktivnostima i široj zajednici može imati negativne posljedice na dobrobit, razvoj i zaštitu djece. Pored toga, mjere koje se pri...mjenjuju kako bi se spriječilo i suzbilo širenje virusa COVID-19 mogu djecu izložiti rizicima u pogledu njihove zaštite. Karantin i mjere izolacije u kućama, objektima i određenim zonama mogu imati negativan utjecaj na djecu i njihove porodice.
Cilj ovog dokumenta je da pruži podršku stručnjacima koji rade na polju zaštite djece kako bi na bolji način odgovorili na rizike za zaštitu djece za vrijeme pandemije virusa COVID-19. U prvom dijelu govori se o tome kakav rizik virus COVID-19 može predstavljati za djecu u smislu njihove zaštite. U drugom dijelu izložene su programske opcije u skladu s Minimalnim standardima za zaštitu djece u humanitarnim akcijama iz 2019. godine (CPMS) i Smjernicama: Zaštita djece za vrijeme epidemija zaraznih bolesti.
more
Dieser Leitfaden zum Management von COVID-19 Ausbruechen richtet sich in erster Linie an die Fachöffentlichkeit im Gesundheitswesen, insbesondere den ÖGD auf allen Ebenen. Er verweist auf viele bereits existierende generische sowie für COVID-19 entwickelten Dokumente. Diese Empfehlungen sind alle... unter www.rki.de/covid-19 zu finden, darunter Empfehlungen für das Kontaktpersonenmanagement, Optionen für die Kontaktreduzierung, Kriterien für die Risiköinschätzung von Grossveranstaltungen und Hilfestellung zum Schutz besonders gefährdeter Gruppen. Informationen für Reisende sind beim Auswärtigen Amt zu finden. Informationen zur regionalen oder lokalen Ebene geben die Landes- und kommunalen Gesundheitsbehörden.
Die Inhalte basieren auf den Erkenntnissen zu Erkrankungen (COVID-19) mit Infektionen durch das neuartige Coronavirus (SARS-CoV-2) zum jeweils angegebenen Datenstand. Das Dokument wird aktualisiert und ergänzt, sobald neue Erkenntnisse eine Aktualisierung/Änderung der Empfehlungen notwendig machen.
more
There is an expanding market of no- and low-alcohol beverages (NoLos). However, their effects on global ethanol consumption and public health are still questioned. Policies and regulations about NoLos’ availability, acceptability and affordability are lacking and evidence about their benefits is l...imited. Concerns have been raised about the impact of NoLos in reducing alcohol consumption and its associated harm and the possible drawbacks and implications, such as misleading minors, pregnant women, abstainers or those seeking to stop drinking about their actual ethanol content. Further, there are concerns about the implications of NoLo branded products being displayed close to the brand’s main alcoholic beverages and their potential to subtly lead to new occasions of drinking. There is a need to monitor their consumption and impact on aggregated alcohol consumption to understand the public health implications of NoLos. The alcohol by volume content of NoLos must be defined, harmonised and clearly labelled. NoLo marketing needs to be regulated to protect children, pregnant women and those seeking to stop drinking. Fiscal and pricing policies to reduce the affordability of products with higher strengths of ethanol may favour a shift towards lower alcohol strength beverages.
more
A lot has happened this year. While we continued to tackle the COVID-19 pandemic, we were hit by disease outbreaks and
humanitarian crises. Yet, despite these challenges, we marched on, resolute in resolving critical health systems issues to increase
access to quality healthcare services. To furth...er our vision and bring concrete actions to reality, under
the leadership of the Government of South Sudan, we developed the Health Sector Strategic Plan to define the strategic
approaches, key interventions, mapping resource needs, and the implementation framework to strengthen the health system
to deliver essential quality health services equitably for 2023 to 2027. For WHO, this Plan will usher in a new reality -- access
to lifesaving or health-promoting interventions is doable and possible, making the health sector fairer, especially for those
unable to pay
more
This document provides technical guidance on concepts, definitions, indicators, criteria, milestones and tools to assist leprosy programmes in their journey towards the goals of interruption of transmission and elimination of leprosy disease and through the post-elimination period. Importantly, it p...rovides criteria with benchmarks, where possible, for all key aspects of leprosy programmes and services. Not only those related to elimination efforts, but also those related to diagnosis and management of leprosy, leprosy-related disabilities, mental wellbeing, stigma and discrimination and inclusion and participation of persons affected by leprosy. The document emphasises that the elimination of leprosy is a long-term, continuous journey on the one hand, while, on the other, clear milestones can be recognised on the way and programme implementation can be assessed against benchmarks, guiding appropriate action to keep the programme on track.
more
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
This document seeks to help health communication professionals working on the topic of immunization more effectively communicate about Events Supposedly Attributed to Vaccination and Immunization (ESAVI) by building trust in National Immunization Programs, understanding risk perceptions related to v...accination, and responding to false information related to vaccination. It includes practical dos and don’ts regarding risk communication and community engagement processes and principles, messaging, risk perceptions, handling false information, collaborating with partners, and pharmacovigilance, as well as real-world examples.
more
World Humanitarian Data and Trends presents global- and country-level data-and-trend analysis about humanitarian
crises and assistance. Its purpose is to consolidate this information and present it in an accessible way, providing policymakers, researchers and humanitarian practitioners with an evid...ence base to support humanitarian policy decisions and provide context for operational decisions.
more
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in patients with non-severe COVID-19
The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19.
The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients.
This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines:
**High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%.
**Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%.
Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk.
Review of COVID-19 treatments for people with non-severe COVID-19
WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022.
If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead.
WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission.
For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol.
WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials.
The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials.
more
The annual Development Co-operation Report brings new evidence, analysis and ideas on
sustainable development to members of the OECD Development Assistance Committee (DAC) and the international community more broadly. The objectives are to promote best practices and innovation in development co-ope...ration and to inform and shape policy reform and behaviour change to realise better lives and the Sustainable Development Goals for all
more
Small drinking-water supplies commonly experience operational, managerial, technical and resourcing challenges that impact their ability to deliver safe and reliable services. The needs and opportunities associated with these supplies therefore warrant explicit consideration in policies and regulati...ons.
These Guidelines, specifically tailored to small water supplies, build on over 60 years of guidance by the World Health Organization (WHO) on drinking-water quality and safety. They focus on establishing drinking-water quality regulations and standards that are health based and context appropriate; on proactively managing risks through water safety planning and sanitary inspections; and on carrying out independent surveillance. The guidance is intended primarily for decision-makers at national and subnational levels with responsibility for developing regulatory frameworks and support programmes related to these activities. Other stakeholders involved in water service provision will also benefit from the guidance in this document.
Designed to be practical and accessible, these Guidelines offer clear guidance that is rooted in the principle of progressive improvement. State-of-the-art recommendations and implementation guidance are provided, drawn from a comprehensive evidence review and established good practices. Additionally, case examples are provided from countries and areas around the world to demonstrate how the guidance in this publication has been implemented in practice in a wide variety of contexts.
Together with WHO’s 2024 Sanitary inspection packages – a supporting tool for the Guidelines for drinking-water quality: small water supplies, these Guidelines update and supersede WHO’s 1997 Guidelines for drinking-water quality. Volume 3: surveillance and control of community supplies. Key changes to this updated publication include a greater focus on preventive risk management and a broader range of small water supplies covered, including those managed by households, communities and professional entities.
more
The Guidelines for drinking-water quality: small water supplies have been developed to address the needs and opportunities associated with small supplies to facilitate progressive improvement towards safe and sustainable drinking-water services for all. These Guidelines are based on the principal re...commendation in the World Health Organization’s Guidelines for drinking-water quality, and they provide guidance on applying that recommendation to small water supplies in particular. These Guidelines aim to help governments and practitioners improve the safety of drinking-water delivered through small supplies.
more
This Community Conversation Kit (CCK) is designed to help people who have a leadership role speak with people in their community about how to protect themselves and those they care about from becoming ill with an infectious disease. This kit will help lead conversations that get people talking with ...each other and thinking differently about their health so they can take action. Using some simple tips and suggestions, the information in this kit will allow communities to exchange practical information that will help them know how to confidently protect their health.
more